Insurance Reimbursement Instructions
06/01/2007: Comprehensive insurance reimbursement information is coming soon.
this page last updated: June 1, 2007
Alpha−1 Antitrypsin Deficiency
Breast & Ovarian Cancer (BRCA)
Colon Cancer Screening: DNA Stool Test
Cystic Fibrosis
Diabetes Risk (deCODE T2™)
DNA Archive™: Home DNA Storage
Hemochromatosis
Infertility
Recurrent Pregnancy Loss
Tamoxifen Response (CYP2D6)
Thrombophilia
Warfarin Response Panel (CYP2C9 and VKORC1)
deCODE T2™ — Diabetes Risk Markers
deCODE T2™ — Why Test Your Patients?
deCODE T2™ — Who Is Appropriate for Testing?
How to Order Testing for Your Patient
Clinical Support Services For Professionals
References
Why Test Your Patients?
Who Is Appropriate for Testing?
Research on Tamoxifen, CYP2D6 and Patient Outcomes
Hormonal Therapy for Postmenopausal Women
Drugs That Inhibit CYP2D6
Drugs Metabolized by CYP2D6
The Cytochrome P450s: Background
References & Online Resources
Our Criteria for Tamoxifen Testing
Our Criteria for Tamoxifen Testing